Traditionally, therapeutic discovery has focused on minute agents, but peptide collaborations are increasingly receiving attention. This novel strategy utilizes combining peptides with other biological modalities to address intricate disease targets. By utilizing the distinctive characteristics of peptides – such as high precision and delivery �